The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

Researchers at the Luxembourg Institute of Health have published a major review in Nature Cancer proposing a new framework to explain and potentially overcome the long-standing resistance of ...

The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...